{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T13:48:24Z","timestamp":1770990504829,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.jpsychires.2012.05.014","type":"journal-article","created":{"date-parts":[[2012,6,30]],"date-time":"2012-06-30T05:47:06Z","timestamp":1341035226000},"page":"1133-1138","source":"Crossref","is-referenced-by-count":84,"title":["Intranasal administration of nanostructured lipid carriers containing CNS acting drug: Pharmacodynamic studies and estimation in blood and brain"],"prefix":"10.1016","volume":"46","author":[{"given":"M. Intakhab","family":"Alam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjula","family":"Baboota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alka","family":"Ahuja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mushir","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javed","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasjeet K.","family":"Sahni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jpsychires.2012.05.014_bib1","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.2174\/1573413711107061014","article-title":"Nanostructured lipid carrier containing CNS acting drug: formulation, optimization and evaluation","volume":"7","author":"Alam","year":"2011","journal-title":"Current Nanoscience"},{"issue":"5","key":"10.1016\/j.jpsychires.2012.05.014_bib2","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ejps.2010.05.003","article-title":"Strategy for effective brain drug delivery","volume":"40","author":"Alam","year":"2010","journal-title":"European Journal of Pharmaceutical Sciences"},{"issue":"14","key":"10.1016\/j.jpsychires.2012.05.014_bib3","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.2174\/138161210791164108","article-title":"Potential of nanoparticulate drug delivery systems by intranasal administration","volume":"16","author":"Ali","year":"2010","journal-title":"Current Pharmaceutical Design"},{"issue":"1","key":"10.1016\/j.jpsychires.2012.05.014_bib4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1211\/jpp.58.1.0008","article-title":"Carbamazepine uptake into rat brain following intra-olfactory transport","volume":"58","author":"Barakat","year":"2006","journal-title":"Journal of Pharmacy and Pharmacology"},{"key":"10.1016\/j.jpsychires.2012.05.014_bib5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0378-5173(96)04752-7","article-title":"Bioavailability of the sedative propiomazine after nasal administration in rats","volume":"144","author":"Bjerre","year":"1996","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.jpsychires.2012.05.014_bib6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0014-2999(01)01628-4","article-title":"Noradrenergic lesions differentially alter the antidepressant-like effect of reboxetine in a modified forced swim test","volume":"436","author":"Cryan","year":"2002","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.jpsychires.2012.05.014_bib7","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0022-3956(02)00060-2","article-title":"Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression","volume":"36","author":"Detke","year":"2002","journal-title":"Journal of Psychiatric Research"},{"issue":"1","key":"10.1016\/j.jpsychires.2012.05.014_bib8","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/BF02245592","article-title":"Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants","volume":"121","author":"Detke","year":"1995","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.jpsychires.2012.05.014_bib9","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/sj.npp.1380263","article-title":"Simultaneous increases of extracellular monoamines in microdialysates from hypothalamus of conscious rats by duloxetine, a dual serotonin and norepinephrine uptake inhibitor","volume":"12","author":"Engleman","year":"1995","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2012.05.014_bib10","first-page":"363","article-title":"Brain delivery of valproic acid via intranasal administration of nanostructured lipid carriers: in-vivo pharmacodynamic studies using rat electroshock model","volume":"6","author":"Eskandari","year":"2011","journal-title":"International Journal of Nanomedicine"},{"key":"10.1016\/j.jpsychires.2012.05.014_bib11","first-page":"1237","article-title":"Tissue distribution of the multidrug resistance protein","volume":"148","author":"Flens","year":"1996","journal-title":"American Journal of Pathology"},{"issue":"1","key":"10.1016\/j.jpsychires.2012.05.014_bib12","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejps.2005.02.008","article-title":"A\u00a0comparative study of the potential of solid triglyceride nanostructures coated with chitosan or poly(ethylene glycol) as carriers for oral calcitonin delivery","volume":"25","author":"Garcia-Fuentes","year":"2005","journal-title":"European Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.jpsychires.2012.05.014_bib13","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.tips.2007.01.007","article-title":"Implications of ATP-binding cassette transporters for brain pharmacotherapies","volume":"28","author":"Hermann","year":"2007","journal-title":"Trends in Pharmacological Sciences"},{"issue":"3","key":"10.1016\/j.jpsychires.2012.05.014_bib14","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.ijbiomac.2012.01.024","article-title":"In-vitro and in-vivo evaluation of oridonin-loaded long circulating nanostructured lipid carriers","volume":"50","author":"Jia","year":"2012","journal-title":"International Journal of Biological Macromolecules"},{"issue":"1\u20132","key":"10.1016\/j.jpsychires.2012.05.014_bib15","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijpharm.2007.05.060","article-title":"Nanostructured lipid carrier (NLC) based gel of celecoxib","volume":"346","author":"Joshi","year":"2008","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.jpsychires.2012.05.014_bib16","first-page":"31","article-title":"Potential new drug delivery system for antidepressants: an overview","volume":"64","author":"Kilts","year":"2003","journal-title":"Journal of Clinical Psychiatry"},{"issue":"2","key":"10.1016\/j.jpsychires.2012.05.014_bib17","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0022-3565(24)36846-6","article-title":"Interaction between the forced swimming test and fluoxetine treatment on extracellular 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in the rat","volume":"282","author":"Kirby","year":"1997","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"1\u20132","key":"10.1016\/j.jpsychires.2012.05.014_bib18","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ijpharm.2008.03.029","article-title":"Intranasal nanoemulsion based brain targeting drug delivery system of risperidone","volume":"358","author":"Kumar","year":"2008","journal-title":"International Journal of Pharmaceutics"},{"issue":"9","key":"10.1016\/j.jpsychires.2012.05.014_bib19","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1124\/dmd.31.9.1142","article-title":"Metabolism, excretion, and pharmacokinetics of duloxetine in healthy human subjects","volume":"31","author":"Lantz","year":"2003","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.jpsychires.2012.05.014_bib20","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrn1728","article-title":"Drug resistance in brain diseases and the role of drug efflux transporters","volume":"6","author":"Loscher","year":"2005","journal-title":"Nature Reviews Neuroscience"},{"key":"10.1016\/j.jpsychires.2012.05.014_bib21","unstructured":"Maggio ET. Intranasal administration of active agents to the central nervous system. US patent 2011;0129462A1; 2011."},{"issue":"2","key":"10.1016\/j.jpsychires.2012.05.014_bib22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jconrel.2005.06.006","article-title":"Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration","volume":"107","author":"Manjunath","year":"2005","journal-title":"Journal of Controlled Release"},{"issue":"4","key":"10.1016\/j.jpsychires.2012.05.014_bib23","first-page":"595","article-title":"Lipid-based colloidal carriers for peptide and protein delivery \u2013 liposomes versus lipid nanoparticles","volume":"2","author":"Martins","year":"2007","journal-title":"International Journal of Nanomedicine"},{"key":"10.1016\/j.jpsychires.2012.05.014_bib24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0169-409X(01)00105-3","article-title":"Solid lipid nanoparticles: production, characterization and applications","volume":"47","author":"Mehnert","year":"2001","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"2","key":"10.1016\/j.jpsychires.2012.05.014_bib25","first-page":"252","article-title":"Drug delivery to the central nervous system: a review","volume":"6","author":"Misra","year":"2003","journal-title":"Journal of Pharmacy and Pharmaceutical Sciences"},{"issue":"1","key":"10.1016\/j.jpsychires.2012.05.014_bib26","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ijpharm.2009.06.019","article-title":"Nanoparticles for direct nose-to-brain delivery of drugs","volume":"379","author":"Mistry","year":"2009","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.jpsychires.2012.05.014_bib27","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1476-5381.2011.01557.x","article-title":"Interactions between antidepressants and P-glycoprotein at the blood\u2013brain barrier: clinical significance of in-vitro and in-vivo findings","volume":"165","author":"O'Brien","year":"2012","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.jpsychires.2012.05.014_bib28","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ijpharm.2008.10.003","article-title":"Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products","volume":"366","author":"Pardeike","year":"2009","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.jpsychires.2012.05.014_bib29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0006-8993(99)01137-3","article-title":"Behavioral organization is independent of locomotor activity in 129 and C57 mouse strains","volume":"835","author":"Paulus","year":"1999","journal-title":"Brain Research"},{"issue":"10","key":"10.1016\/j.jpsychires.2012.05.014_bib30","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1017\/S1461145709990484","article-title":"Plasma levels and cerebrospinal fluid penetration by duloxetine in a patient with a non-fatal overdose during a suicide attempt","volume":"12","author":"Paulzen","year":"2009","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.jpsychires.2012.05.014_bib31","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00213-004-2048-7","article-title":"Forced swimming test in mice: a review of antidepressant activity","volume":"177","author":"Petit-Demouliere","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2012.05.014_bib32","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0014-2999(78)90414-4","article-title":"\u201cBehavioral despair\u201d in rats and mice: strain differences and the effect of imipramine","volume":"51","author":"Porsolt","year":"1978","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.jpsychires.2012.05.014_bib33","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/266730a0","article-title":"Depression: a new animal model sensitive to antidepressant treatments","volume":"266","author":"Porsolt","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.jpsychires.2012.05.014_bib34","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1248\/cpb.39.2456","article-title":"The transport of a drug to the cerebrospinal fluid directly from the nasal cavity: the relation to the lipophilicity of the drug","volume":"39","author":"Sakane","year":"1991","journal-title":"Chemical and Pharmaceutical Bulletin"},{"key":"10.1016\/j.jpsychires.2012.05.014_bib35","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0378-5173(01)00882-1","article-title":"Effect of lipid matrix and size of solid lipid nanoparticles (SLN) on the viability and cytokine production of macrophages","volume":"231","author":"Scholer","year":"2002","journal-title":"International Journal of Pharmaceutics"},{"issue":"5","key":"10.1016\/j.jpsychires.2012.05.014_bib36","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/02652040500162436","article-title":"SLN and NLC for topical delivery of ketoconazole","volume":"22","author":"Souto","year":"2005","journal-title":"Journal of Microencapsulation"},{"key":"10.1016\/j.jpsychires.2012.05.014_bib37","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ejpb.2007.01.015","article-title":"Cetyl palmitate-based NLC for topical delivery of Coenzyme Q10 \u2013 development, physicochemical characterization and in-vitro release studies","volume":"67","author":"Teeranachaideekul","year":"2007","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"key":"10.1016\/j.jpsychires.2012.05.014_bib38","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.neuroscience.2008.01.013","article-title":"Delivery of interferon-\u03b2 to the monkey nervous system following intranasal administration","volume":"152","author":"Thorne","year":"2008","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.jpsychires.2012.05.014_bib39","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.neuroscience.2004.05.029","article-title":"Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration","volume":"127","author":"Thorne","year":"2004","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.jpsychires.2012.05.014_bib40","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ijpharm.2011.12.009","article-title":"Baicalein loaded in tocol nanostructured lipid carriers (tocol NLCs) for enhanced stability and brain targeting","volume":"423","author":"Tsai","year":"2012","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.jpsychires.2012.05.014_bib41","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s00228-009-0714-8","article-title":"Blood-brain barrier transporters and response to CNS-active drugs","volume":"65","author":"Urquhart","year":"2009","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1016\/j.jpsychires.2012.05.014_bib42","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ijpharm.2010.03.011","article-title":"Nanostructured lipid carriers constituted from high-density lipoprotein components for delivery of a lipophilic cardiovascular drug","volume":"391","author":"Zhang","year":"2010","journal-title":"International Journal of Pharmaceutics"},{"issue":"12","key":"10.1016\/j.jpsychires.2012.05.014_bib43","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1248\/cpb.56.1645","article-title":"Preparation of a dispersible pegylate nanostructured lipid carriers (NLC) loaded with 10-hydroxycamptothecin by spray-drying","volume":"56","author":"Zhang","year":"2008","journal-title":"Chemical and Pharmaceutical Bulletin"},{"issue":"31","key":"10.1016\/j.jpsychires.2012.05.014_bib44","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1016\/j.jchromb.2011.10.015","article-title":"Pharmacokinetics and tissue distribution of docetaxel by liquid chromatography-mass spectrometry: evaluation of folate receptor-targeting amphiphilic copolymer modified nanostructured lipid carrier","volume":"879","author":"Zhao","year":"2011","journal-title":"Journal of Chromatography B"}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395612001677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395612001677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:05:28Z","timestamp":1743638728000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395612001677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":44,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0022395612001677"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2012.05.014","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}